1. Home
  2. ALTI vs TTRX Comparison

ALTI vs TTRX Comparison

Compare ALTI & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

N/A

Current Price

$1.57

Market Cap

334.9M

Sector

Finance

ML Signal

N/A

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$8.63

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALTI
TTRX
Founded
2020
2015
Country
United States
United States
Employees
490
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
334.9M
298.8M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
ALTI
TTRX
Price
$1.57
$8.63
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $25.00
AVG Volume (30 Days)
★ 266.5K
86.5K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.11
N/A
EPS
★ N/A
N/A
Revenue
★ $254,956,000.00
N/A
Revenue This Year
$17.39
N/A
Revenue Next Year
$9.19
$900.00
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 23.21
N/A
52 Week Low
$1.25
$2.60
52 Week High
$5.45
$16.45

Technical Indicators

Market Signals
Indicator
ALTI
TTRX
Relative Strength Index (RSI) 32.69 37.87
Support Level N/A $7.68
Resistance Level $3.97 $11.17
Average True Range (ATR) 0.28 1.04
MACD -0.05 -0.07
Stochastic Oscillator 20.47 15.21

Price Performance

Historical Comparison
ALTI
TTRX

About ALTI AlTi Global Inc.

AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: